Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Daria D'Ambrosio"'
Autor:
Franco Scaldaferri, Daria D'Ambrosio, Grainne Holleran, Andrea Poscia, Valentina Petito, Loris Lopetuso, Cristina Graziani, Lucrezia Laterza, Maria Teresa Pistone, Silvia Pecere, Diego Currò, Eleonora Gaetani, Alessandro Armuzzi, Alfredo Papa, Giovanni Cammarota, Antonio Gasbarrini
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186575 (2017)
Infliximab is an effective treatment for inflammatory bowel disease (IBD). Studies differ regarding the influence of body mass index (BMI) on the response to infliximab, with the majority of studies indicating that increased BMI may be associated wit
Externí odkaz:
https://doaj.org/article/0195a07c53f946a78f6acb557e735877
Autor:
Anna Paola Mitterhofer, Daria D’Ambrosio, Alessandro Corsi, Stefano Ginanni Corradini, Barbara Lattanzi, Manuela Merli, Daniele Tavano, Massimo Rossi, Marialuisa Framarino dei Malatesta, Jean de Ville de Goyet, Gianluca Mennini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a34ee3c30707f92be6cd980581d58d1a
http://hdl.handle.net/11573/1572130
http://hdl.handle.net/11573/1572130
Autor:
Simone Incicco, Oliviero Riggio, Daria D’Ambrosio, Mario Venditti, Manuela Merli, Cristina Lucidi, Barbara Lattanzi, Vincenza Di Gregorio
Publikováno v:
Liver International. 38:851-857
BACKGROUND & AIMS Severe infections and muscle wasting are both associated to poor outcome in cirrhosis. A possible synergic effect of these two entities in cirrhotic patients has not been previously investigated. We aimed at analysing if a low muscl
Autor:
Angelo Bruni, Maurizio Muscaritoli, Barbara Lattanzi, Manuela Merli, Nicoletta Fabrini, A. Pigliacelli, Daria D’Ambrosio, Flaminia Ferri
Publikováno v:
Digestive and Liver Disease. 52:S162-S163
Autor:
Barbara, Lattanzi, Daria, D'Ambrosio, Daniele, Tavano, Demis, Pitoni, Gianluca, Mennini, Stefano, Ginanni Corradini, Massimo, Rossi, Manuela, Merli
Publikováno v:
Nutrients
The development of nutritional and metabolic abnormalities represents an important burden in patients after liver transplantation (LT). Our study aimed at evaluating the incidence, time of onset, and risk factors for nutritional and metabolic abnorma
Publikováno v:
Frailty and Sarcopenia in Cirrhosis ISBN: 9783030262259
Sarcopenia and frailty are frequent in liver cirrhosis and are associated with a worse prognosis. For this reason, and being potentially modifiable disorders, to find a strategy to prevent or improve these conditions is of great importance in cirrhot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cbe934f593b7d6ca64db39d688a8f0e
https://doi.org/10.1007/978-3-030-26226-6_6
https://doi.org/10.1007/978-3-030-26226-6_6
Autor:
Gianluca Mennini, Daria D’Ambrosio, Massimo Rossi, Michela Giusto, Alessio Farcomeni, Carlina V. Albanese, Manuela Merli, Stefano Ginanni Corradini, Barbara Lattanzi
Publikováno v:
Nutrients
Volume 11
Issue 9
Nutrients, Vol 11, Iss 9, p 2259 (2019)
Volume 11
Issue 9
Nutrients, Vol 11, Iss 9, p 2259 (2019)
Sarcopenia is a frequent complication in liver transplant (LT) recipients. &beta
hydroxy-&beta
methyl-butyrate (HMB) has the potential to increase muscle-performance and tropism. Our study aims at evaluating the effect on muscle mass and fu
hydroxy-&beta
methyl-butyrate (HMB) has the potential to increase muscle-performance and tropism. Our study aims at evaluating the effect on muscle mass and fu
Autor:
Oliviero Riggio, Alessio Farcomeni, Silvia Nardelli, Manuela Merli, Daria D’Ambrosio, Stefania Gioia, Daniele Tavano, Barbara Lattanzi, Simone Di Cola
Publikováno v:
Liver international : official journal of the International Association for the Study of the LiverREFERENCES. 39(10)
Background & aims Little is known on nutritional parameters in patients with chronic portal vein thrombosis (PVT) and idiopathic non-cirrhotic portal hypertension (INCPH). The study aims to assess the prevalence and the clinical impact of sarcopenia
Autor:
A. Pigliacelli, Alessio Farcomeni, Stefano Ginanni Corradini, Daria D’Ambrosio, Gianluca Mennini, Cristina Lucidi, Silvia Nardelli, Manuela Merli, Oliviero Riggio, Simone Di Cola, Massimo Rossi, Stefania Gioia, Barbara Lattanzi
Background Since the use of the Model for End-Stage Liver Disease (MELD) score for establishing the prognosis of cirrhotic patients has been introduced, questions have been raised whether complications of liver cirrhosis would provide additional info
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5222d3676f536cd6922e142079131a03
http://hdl.handle.net/2108/278618
http://hdl.handle.net/2108/278618
Sarcopenia is an important burden in liver cirrhosis representing a negative prognostic factor for mortality. Moreover, sarcopenia is an independent predictor of complications in patients with liver cirrhosis, including Hepatic Encephalopathy (HE). A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdcca7b777bd9ee4f9f5f7e542c990f0
http://hdl.handle.net/11573/1281304
http://hdl.handle.net/11573/1281304